New data: With no booster, nursing home residents face 30 percent higher COVID risk
By
Alicia Lasek
Jan 29, 2023
Nursing home residents who have received the COVID-19 bivalent booster shot are 30% to 50% less likely to become infected with SARS-CoV-2 than their fellow residents who haven’t gotten boosted, the...
WHO turns attention to fungal infections as drug resistance builds
By
Alicia Lasek
Oct 26, 2022
The World Health Organization has created a first-ever priority list of fungi that it says pose the greatest emerging threats to public health.
Federal ‘all or none’ sepsis policy a wash in multi-hospital study
By
Alicia Lasek
Apr 20, 2021
SEP-1 requirements meant to combat staggering sepsis rates in the U.S. did not lead to clinically meaningful patient outcomes in 11 UPMC hospitals, physician-scientists say.
FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...
Industry advocates have launched an online platform and forum open to all LTC staff who perform infection prevention and control duties.
U.S., Canada ‘not that different’ in LTC staff response to pandemic work conditions: study
By
Alicia Lasek
Feb 19, 2021
“We talk about how great Canada’s healthcare system is vis-à-vis that of the United States … but we are not that different when it comes to long-term care,” the researchers say.
AHA’s new heart-health dietary advice highlights personal patterns, style
By
Alicia Lasek
Nov 23, 2021
The emphasis is now on dietary patterns, not specific foods or nutrients, the lead author says. “And it’s not just about what people shouldn’t be eating.”
Merck to seek emergency use for COVID-19 antiviral pill that cuts severe outcomes by 50 percent
By
Alicia Lasek
Oct 04, 2021
Molnupiravir has reduced COVID-19 deaths and hospitalizations by half in a new clinical trial. An orally delivered drug could offer unprecedented treatment convenience, the drug’s developers say.
U.S. COVID-19 strategy must veer to protecting the vulnerable, experts say
By
Alicia Lasek
Mar 22, 2022
When planning for a future with COVID-19, some clinicians believe that the public health focus should turn from stopping transmission to protecting those most likely to become severely ill, according to...
U.S. lawmakers ramp up scrutiny of FDA following agency’s approval of controversial Alzheimer’s drug
By
Alicia Lasek
Sep 07, 2021
The FDA is being asked to help explain how Aduhelm (aducanumab) met accelerated approval criteria when so many experts — including internal advisers — have flagged insufficient safety and efficacy...